Skip to main content
PMC home page
British Journal of Cancer logoLink to British Journal of Cancer
editorial
. 1990 Jun;61(6):795–796. doi: 10.1038/bjc.1990.179

Treatment of screen detected ductal carcinoma in situ: a silver lining within a grey cloud?

I S Fentiman
PMCID: PMC1971702  PMID: 2164832

Full text

PDF

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Cuzick J., Baum M. Tamoxifen and contralateral breast cancer. Lancet. 1985 Aug 3;2(8449):282–282. doi: 10.1016/s0140-6736(85)90338-1. [DOI] [PubMed] [Google Scholar]
  2. Cuzick J., Stewart H., Peto R., Baum M., Fisher B., Host H., Lythgoe J. P., Ribeiro G., Scheurlen H., Wallgren A. Overview of randomized trials of postoperative adjuvant radiotherapy in breast cancer. Cancer Treat Rep. 1987 Jan;71(1):15–29. [PubMed] [Google Scholar]
  3. Fentiman I. S., Powles T. J. Tamoxifen and benign breast problems. Lancet. 1987 Nov 7;2(8567):1070–1072. doi: 10.1016/s0140-6736(87)91491-7. [DOI] [PubMed] [Google Scholar]
  4. Lagios M. D., Margolin F. R., Westdahl P. R., Rose M. R. Mammographically detected duct carcinoma in situ. Frequency of local recurrence following tylectomy and prognostic effect of nuclear grade on local recurrence. Cancer. 1989 Feb 15;63(4):618–624. doi: 10.1002/1097-0142(19890215)63:4<618::aid-cncr2820630403>3.0.co;2-j. [DOI] [PubMed] [Google Scholar]
  5. Roberts M. M., Alexander F. E., Anderson T. J., Chetty U., Donnan P. T., Forrest P., Hepburn W., Huggins A., Kirkpatrick A. E., Lamb J. Edinburgh trial of screening for breast cancer: mortality at seven years. Lancet. 1990 Feb 3;335(8684):241–246. doi: 10.1016/0140-6736(90)90066-e. [DOI] [PubMed] [Google Scholar]
  6. Shapiro S., Venet W., Strax P., Venet L., Roeser R. Ten- to fourteen-year effect of screening on breast cancer mortality. J Natl Cancer Inst. 1982 Aug;69(2):349–355. [PubMed] [Google Scholar]
  7. Tabár L., Fagerberg C. J., Gad A., Baldetorp L., Holmberg L. H., Gröntoft O., Ljungquist U., Lundström B., Månson J. C., Eklund G. Reduction in mortality from breast cancer after mass screening with mammography. Randomised trial from the Breast Cancer Screening Working Group of the Swedish National Board of Health and Welfare. Lancet. 1985 Apr 13;1(8433):829–832. doi: 10.1016/s0140-6736(85)92204-4. [DOI] [PubMed] [Google Scholar]
  8. Wang H. H., Ducatman B. S., Eick D. Comparative features of ductal carcinoma in situ and infiltrating ductal carcinoma of the breast on fine-needle aspiration biopsy. Am J Clin Pathol. 1989 Dec;92(6):736–740. doi: 10.1093/ajcp/92.6.736. [DOI] [PubMed] [Google Scholar]
  9. van Dongen J. A., Fentiman I. S., Harris J. R., Holland R., Peterse J. L., Salvadori B., Stewart H. J. In-situ breast cancer: the EORTC consensus meeting. Lancet. 1989 Jul 1;2(8653):25–27. doi: 10.1016/s0140-6736(89)90263-8. [DOI] [PubMed] [Google Scholar]
  10. van de Vijver M. J., Peterse J. L., Mooi W. J., Wisman P., Lomans J., Dalesio O., Nusse R. Neu-protein overexpression in breast cancer. Association with comedo-type ductal carcinoma in situ and limited prognostic value in stage II breast cancer. N Engl J Med. 1988 Nov 10;319(19):1239–1245. doi: 10.1056/NEJM198811103191902. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES